Diagnostic accuracy of NLR, CRP, and PCT in predicting mortality outcomes. All three biomarkers demonstrated high sensitivity (91.2%), but low to moderate specificity. CRP showed the highest AUC, indicating slightly better discriminative performance compared to NLR and PCT. AUC: area under the curve; CRP: C-reactive protein; NLR: neutrophil-to-lymphocyte ratio; PCT: procalcitonin.
Declarations
Author contributions
ID and IN: Conceptualization, Writing—review & editing, Investigation, Visualization, Funding acquisition. DRN: Data curation, Formal analysis, Writing—review & editing. RR: Formal analysis, Writing—original draft, Writing—review & editing, Visualization. DLT: Supervision, Writing—review & editing. All authors read and approved the submitted version.
Conflicts of interest
The authors declare that there are no conflicts of interest.
Ethical approval
This study was approved by the Health Research Ethics Commission, Faculty of Medicine, Hasanuddin University (No. 670/UN4.6.4.5.31/PP36/2023). This study complies with the 2013 Declaration of Helsinki.
Consent to participate
Informed consent to participate in the study was obtained from all participants.
Consent to publication
Not applicable.
Availability of data and materials
Data supporting the results of this study are included in the manuscript. Additional information is available from the corresponding author upon reasonable request.
Funding
This study was supported by the BLU (Public Service Agency) fund of RSUP Dr. Wahidin Sudirohusodo (No. HK.02.03/DXIX/23369/2024). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
Yang T, Wan C, Wang H, Qin J, Chen L, Shen Y, et al. The prognostic and risk-stratified value of neutrophil–lymphocyte count ratio in Chinese patients with community-acquired pneumonia.Eur J Inflamm. 2017;15:22–7. [DOI]
Corica B, Tartaglia F, D’Amico T, Romiti GF, Cangemi R. Sex and gender differences in community-acquired pneumonia.Intern Emerg Med. 2022;17:1575–88. [DOI] [PubMed] [PMC]
de Miguel-Díez J, Jiménez-García R, Hernández-Barrera V, Jiménez-Trujillo I, de Miguel-Yanes JM, Méndez-Bailón M, et al. Trends in hospitalizations for community-acquired pneumonia in Spain: 2004 to 2013.Eur J Intern Med. 2017;40:64–71. [DOI] [PubMed]
Naheed A, Breiman RF, Islam MS, Saha SK, Tabassum Naved R. Disparities by sex in care-seeking behaviors and treatment outcomes for pneumonia among children admitted to hospitals in Bangladesh.PLoS One. 2019;14:e0213238. [DOI] [PubMed] [PMC]
López-de-Andrés A, Albaladejo-Vicente R, de Miguel-Diez J, Hernández-Barrera V, Ji Z, Zamorano-León JJ, et al. Gender differences in incidence and in-hospital outcomes of community-acquired, ventilator-associated and nonventilator hospital-acquired pneumonia in Spain.Int J Clin Pract. 2021;75:e13762. [DOI] [PubMed]
Reade MC, Yende S, D’Angelo G, Kong L, Kellum JA, Barnato AE, et al.; Genetic and Inflammatory Markers of Sepsis Investigators. Differences in immune response may explain lower survival among older men with pneumonia.Crit Care Med. 2009;37:1655–62. [DOI] [PubMed] [PMC]
Kuikel S, Pathak N, Poudel S, Thapa S, Bhattarai SL, Chaudhary G, et al. Neutrophil-lymphocyte ratio as a predictor of adverse outcome in patients with community-acquired pneumonia: A systematic review.Health Sci Rep. 2022;5:e630. [DOI] [PubMed] [PMC]
Chebib N, Cuvelier C, Malézieux-Picard A, Parent T, Roux X, Fassier T, et al. Pneumonia prevention in the elderly patients: the other sides.Aging Clin Exp Res. 2021;33:1091–100. [DOI] [PubMed]
Singh B, Goyal A, Patel BC. C-Reactive Protein: Clinical Relevance and Interpretation.In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2026.
Ponnappan S, Ponnappan U. Aging and immune function: molecular mechanisms to interventions.Antioxid Redox Signal. 2011;14:1551–85. [DOI] [PubMed] [PMC]
Goronzy JJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines.Nat Immunol. 2013;14:428–36. [DOI] [PubMed] [PMC]
Khanzadeh S, Lucke-Wold B, Eshghyar F, Rezaei K, Clark A. The Neutrophil to Lymphocyte Ratio in Poststroke Infection: A Systematic Review and Meta-Analysis.Dis Markers. 2022;2022:1983455. [DOI] [PubMed] [PMC]
Shojaan H, Kalami N, Ghasempour Alamdari M, Emami Alorizy SM, Ghaedi A, Bazrgar A, et al. Diagnostic value of the neutrophil lymphocyte ratio in discrimination between tuberculosis and bacterial community acquired pneumonia: A meta-analysis.J Clin Tuberc Other Mycobact Dis. 2023;33:100395. [DOI] [PubMed] [PMC]
Malézieux-Picard A, Nascè A, Azurmendi L, Pagano S, Vuilleumier N, Sanchez JC, et al. Kinetics of inflammatory biomarkers to predict one-year mortality in older patients hospitalized for pneumonia: a multivariable analysis.Int J Infect Dis. 2022;122:63–9. [DOI] [PubMed]
Tekin A, Wireko FW, Gajic O, Odeyemi YE. The Neutrophil/Lymphocyte Ratio and Outcomes in Hospitalized Patients with Community-Acquired Pneumonia: A Retrospective Cohort Study.Biomedicines. 2024;12:260. [DOI] [PubMed] [PMC]
Liu D, Su LX, Guan W, Xiao K, Xie LX. Prognostic value of procalcitonin in pneumonia: A systematic review and meta-analysis.Respirology. 2016;21:280–8. [DOI] [PubMed] [PMC]
Akagi T, Nagata N, Miyazaki H, Harada T, Takeda S, Yoshida Y, et al. Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital.BMC Geriatr. 2019;19:3. [DOI] [PubMed] [PMC]
Sharma Y, Thompson C, Zinellu A, Shahi R, Horwood C, Mangoni AA. The role of the neutrophil-to-lymphocyte ratio in predicting outcomes among patients with community-acquired pneumonia.Clin Med (Lond). 2025;25:100278. [DOI] [PubMed] [PMC]
Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.J Gerontol A Biol Sci Med Sci. 2014;69 Suppl 1:S4–9. [DOI] [PubMed]
Curbelo J, Luquero Bueno S, Galván-Román JM, Ortega-Gómez M, Rajas O, Fernández-Jiménez G, et al. Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio.PLoS One. 2017;12:e0173947. [DOI] [PubMed] [PMC]
Harrison M, Collins CD. Is procalcitonin-guided antimicrobial use cost-effective in adult patients with suspected bacterial infection and sepsis?Infect Control Hosp Epidemiol. 2015;36:265–72. [DOI] [PubMed]
